Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 221 - 240 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

CVSI ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against CV Sciences, Inc.; Important Oct. 23 Deadline - CVSI

NEW YORK, Oct. 20, 2018 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of CV Sciences, Inc. (OTC: CVSI) from June 19, 2017 through August 20, 2018, inclusive (the "Class Period"). The... Read more ››

By: PR Newswire Association LLC. - 20 Oct 2018
Related companies:  CV Sciences Inc.

BioLineRx Discloses Additional Data from Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer at ESMO 2018 Congress

TEL AVIV, Israel, October 20, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 20 Oct 2018

OncoMed Announces Interim Phase 1b Results for Navicixizumab and Paclitaxel Combination Therapy in Platinum-resistant Ovarian Cancer

Read more ››
By: Nasdaq / GlobenewsWire - 20 Oct 2018
Related companies:  OncoMed Pharmaceuticals, Inc.

Dynavax’s SD-101 in Combination with KEYTRUDA® (pembrolizumab) Continues to Show a 70% Overall Response Rate in Advanced Melanoma Patients According to Data Presented Today at the ESMO 2018 Congress

Read more ››
By: Nasdaq / GlobenewsWire - 20 Oct 2018
Related companies:  Dynavax Technologies Corporation

INNATE PHARMA : Phase II results from monalizumab/cetuximab in head and neck cancer at ESMO

Read more ››
By: Nasdaq / GlobenewsWire - 20 Oct 2018
Related companies:  Innate Pharma S.A.

TWi Biotechnology, Inc. Announced the initiation of Phase 2 Proof-of-Concept Clinical Trial of AC-203 for Treatment of Inherited Epidermolysis Bullosa

TAIPEI, Taiwan, Oct. 20, 2018 /PRNewswire/ -- TWi Biotechnology, Inc. (6610 TTO), a clinical stage biotechnology company focused on developing novel inhibitors of inflammasomes, today announced that it has enrolled the first patient in a phase 2 trial of AC-203 for the treatment of inherited... Read more ››

By: PR Newswire Association LLC. - 20 Oct 2018
Related companies:  TWI Ltd | TWi Pharmaceuticals, Inc. | TWi Biotechnology, Inc 

Agenus Presents Clinical Data on Its PD-1 & CTLA-4 at ESMO 2018

LEXINGTON, Mass., Oct. 20, 2018 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune checkpoint antibodies, cancer vaccines, and adoptive cell therapies(2), presented updated clinical data on its lead CTLA-4 and PD-1 programs today at the 2018... Read more ››

By: PR Newswire Association LLC. - 20 Oct 2018

Cantargia Presented Positive Phase I Clinical Data with Lead Candidate CAN04 at ESMO

STOCKHOLM, Oct. 20, 2018 /PRNewswire/ -- The antibody CAN04 was well tolerated and 6 mg/kg is a safe dose

Read more ››
By: PR Newswire Association LLC. - 20 Oct 2018

TESARO Announces Data Presentations at ESMO 2018 Congress

Read more ››
By: Nasdaq / GlobenewsWire - 20 Oct 2018
Related companies:  TESARO, Inc.

ESMO 2018 Press Release - Regular Exercise Should be Part of Cancer Care for all Patients

MUNICH, October 20, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 20 Oct 2018

Qfix Releases New Solution to Improve Patient Transport and Brachytherapy Workflows

AVONDALE, Pa., Oct. 19, 2018 /PRNewswire/ -- Qfix announces the launch of the new Brachytherapy Transfer Device for the Symphony(TM) Patient Transport System. The Symphony(TM) System improves workflow efficiencies and throughput by seamlessly aiding in the setup, positioning and transfer of patients... Read more ››

By: PR Newswire Association LLC. - 20 Oct 2018
Related companies:  Qfix

Qfix® Revolutionizes Adaptive Thermoplastic Masks for Intracranial, Head and Neck Cancer Treatment

AVONDALE, Pa., Oct. 19, 2018 /PRNewswire/ -- Qfix introduces a new line of thermoplastic masks for fractionated intracranial head and neck cancer treatments. Over the course of treatment, patient anatomy can change due to various medications and treatment side effects. The patent pending Integrated... Read more ››

By: PR Newswire Association LLC. - 20 Oct 2018
Related companies:  Qfix

BERG to Present New Data Describing Details on Progress of its Oncology Portfolio and Precision Medicine Applications at the European Society for Medical Oncology 2018 Congress

BOSTON, Oct. 19, 2018 /PRNewswire/ -- BERG LLC, a Boston-based biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced the presentation of three posters on the progression of its oncology and artificial intelligence (AI)/Biomarker portfolio... Read more ››

By: PR Newswire Association LLC. - 20 Oct 2018
Related companies:  Chemische Fabrik Berg GmbH

LumiThera, Inc. Selected to Present at the Ophthalmology Innovation Summit 2018 at the American Academy of Ophthalmology, Chicago, IL

SEATTLE, Oct. 19, 2018 /CNW/ -- LumiThera(®) Inc., a commercial-stage medical device company focused on developing photobiomodulation (PBM) therapies for ocular disorders and disease, today announced that it will present at the Ophthalmology Innovation Summit at the American Academy of Ophthalmology... Read more ››

By: PR Newswire Association LLC. - 20 Oct 2018
Related companies:  LumiThera, Inc.

Bespoke Extracts Sponsors Motorcycle Racer Sean Dylan Kelly at 35th Annual Race of Champions at Daytona International Speedway

Read more ››
By: Nasdaq / GlobenewsWire - 19 Oct 2018

Correction of Press Release dated September 24, 2018 (‘Golden Leaf Holdings' Subsidiary, Medical Marijuana Group Corp, Acquires Sales License from Health Canada’)

Read more ››
By: Nasdaq / GlobenewsWire - 19 Oct 2018

Amarin Announces Mandatory Exchange of Exchangeable Senior Notes Issued in January 2017

Read more ››
By: Nasdaq / GlobenewsWire - 19 Oct 2018
Related companies:  Amarin Corporation plc

Globus Medical Schedules Third Quarter 2018 Earnings Release and Conference Call

Read more ››
By: Nasdaq / GlobenewsWire - 19 Oct 2018
Related companies:  Globus Medical Inc.

Syneos Health Schedules Third Quarter 2018 Earnings Call for Tuesday, November 6, 2018

Read more ››
By: Nasdaq / GlobenewsWire - 19 Oct 2018
Related companies:  Syneos Health, Inc

Sanofi: FDA approves asthma indication for Dupixent® (dupilumab)

Read more ››
By: Nasdaq / GlobenewsWire - 19 Oct 2018
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑